Business Context and Reporting Period
This Form 6-K filing by SciSparc Ltd. covers the month of February 2022, with the report dated February 17, 2022. The filing discloses a significant legal development involving a lawsuit filed by the Company against six former directors, including former interim CEO and executive chairman Dr. Ascher Shmulewitz.
Key Financial Metrics
The filing text does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The only financial figure disclosed relates to the damages sought in the pending litigation.
Material Changes and Legal Proceedings
On February 15, 2022, SciSparc Ltd. filed a suit (Case No. 34426-02-22) with the Tel Aviv-Jaffa District Court. The lawsuit alleges breaches of fiduciary duties (duty of care and duty of loyalty) by the former directors regarding a transaction approved in August 2018. The transaction involved the acquisition of eight pain clinics and a laboratory from Anesthesia Services Associates PLLC via a subsidiary, Therapix Healthcare Resources, Inc.
- Claimed Damages: NIS 13,114,200 (approximately $4.12 million).
- Basis for Damages: Amounts invested in the transaction and indirect expenses incurred by the Company.
- Outcome: The Company states it cannot currently predict the likelihood of success.
Guidance, Outlook, and Risks
The filing highlights a material contingency regarding the outcome of the lawsuit against former directors. Management has not provided specific financial guidance or operational outlook in this document. The primary risk identified is the uncertainty surrounding the litigation and the potential impact of the alleged harm caused by the 2018 transaction.
Investor Verification Checklist
- Verify the current status of the lawsuit (Case No. 34426-02-22) filed in the Tel Aviv-Jaffa District Court.
- Review the details of the August 2018 acquisition of pain clinics and the laboratory to understand the alleged breach of fiduciary duty.
- Assess the potential financial impact of the $4.12 million damages claim on the Company's balance sheet.
- Monitor for any updates on the Company's liquidity and operational status, as this filing does not contain recent financial statements.